Skip to main content
. 2019 Nov 21;10(7):1294–1308. doi: 10.1016/j.apsb.2019.11.011

Figure 3.

Figure 3

Preliminary in vivo anticancer activity of compounds 25a and 30a. (A) Antitumor potency of compounds 25a and 30a in the HCT116 xenograft models implanted in BALB/c nude mice. Data were expressed as means ± SEM (n = 5 per group). **P < 0.01, ***P < 0.001, determined with Student's t test. (B) The change of body weight during the test.